The evolving role of dendritic cells in cancer therapy

Expert Opinion on Biological Therapy
E J IlettA A Melcher

Abstract

Dendritic cells (DC) are a clear choice for use in cancer immunotherapy, and much research has focused on generating DC for clinical use. Although DC therapy has been successful in inducing specific anti-tumour immune responses, these have rarely translated into clinical efficacy. We examine some of the components of generating DC for therapy, including their culture, antigen loading and delivery, and discuss why DC therapy has not yet delivered substantial clinical benefit. We also examine more novel approaches, such as the potential for combination DC-based immunomodulatory strategies. Given the highly immunosuppressive tumour environment, many of the approaches to DC vaccination are unlikely to result in effective therapy, as even successfully primed T cells may fail to infiltrate tumours or be anergized after entry. Broader approaches against multiple tumour-associated antigens in the context of overcoming tumour immune suppression are likely to prove more successful. The combination of oncolytic viral therapy with DC vaccines may promote an inflammatory tumour environment, inducing optimal DC activation, T cell priming and effective therapy. Evolving DC-based therapeutic strategies addressing multiple components of tumour-...Continue Reading

References

Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·C A Janeway
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Aug 1, 1996·The Journal of Experimental Medicine·M A Alexander-MillerJ A Berzofsky
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Feb 2, 1999·The Journal of Experimental Medicine·J G Cyster
Feb 24, 2001·The Journal of Experimental Medicine·M V DhodapkarN Bhardwaj
Feb 28, 2001·Cancer Immunology, Immunotherapy : CII·L M RealF Ruiz-Cabello
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L FongE G Engleman
Feb 5, 2002·Immunity·Eric J Kunkel, Eugene C Butcher
Apr 3, 2002·Seminars in Cancer Biology·Alain P VicariGiorgio Trinchieri
Feb 26, 2003·Gene Therapy·F GrünebachP Brossart
Mar 5, 2003·Trends in Immunology·Adrian E Morelli, Angus W Thomson
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marc DauerAndreas Eigler
Nov 6, 2003·Cancer Immunology, Immunotherapy : CII·Peter HerseyMargaret Lett
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jan C DuddaStefan Martin
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robin M CiscoScott K Pruitt
Aug 17, 2004·Cancer Immunology, Immunotherapy : CII·Luisa NovellinoGiorgio Parmiani
Sep 30, 2004·Nature Immunology·Akiko Iwasaki, Ruslan Medzhitov
Mar 16, 2005·Current Opinion in Immunology·Gosse J AdemaCarl G Figdor
Apr 1, 2005·International Journal of Cancer. Journal International Du Cancer·Esperanza FeijoóIgnacio Melero
Apr 2, 2005·Nature Reviews. Immunology·Jacques Banchereau, A Karolina Palucka
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Linda M LiauMichael D Roth
Aug 3, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicolas van BarenThierry Boon
Nov 1, 2005·Nature Biotechnology·I Jolanda M de VriesCarl G Figdor
May 13, 2006·Nature Reviews. Immunology·Caetano Reis e Sousa
May 16, 2006·Journal of Immunotherapy·Thomas F GajewskiHelena Harlin
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amelia GroverPatrick Hwu
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ianko D IankovStephen J Russell
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anthony T PowerJohn C Bell
Jan 6, 2007·International Journal of Cancer. Journal International Du Cancer·Kei TomiharaHirofumi Hamada

❮ Previous
Next ❯

Citations

Sep 2, 2010·Cell Research·Philip C Calder
Apr 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alan MelcherJohn C Bell
Aug 16, 2012·Cancer Biotherapy & Radiopharmaceuticals·Frances Ka-Yin Lin, Yiu-Loon Chui
Jul 31, 2010·Journal of Biomedicine & Biotechnology·Bo JinAnthony E T Yeo
Jun 8, 2011·The Journal of Clinical Investigation·Norman WollerFlorian Kühnel
Apr 6, 2011·Immunotherapy·John CopierAngus Dalgleish
Aug 13, 2010·Clinical Medicine Insights. Oncology·Joseph F Murphy
Oct 13, 2011·Expert Review of Vaccines·Erin L LousbergJohn D Hayball
Sep 17, 2011·Medicinal Research Reviews·Frederick HarrisDavid A Phoenix
May 18, 2012·Journal of Experimental & Clinical Cancer Research : CR·Alexander Shimabukuro-VornhagenMichael S von Bergwelt-Baildon
Jul 1, 2015·Critical Reviews in Oncology/hematology·Alessandro AllegraCaterina Musolino
Jan 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Yan-Xia HuJi-Duo Shen
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jun LuAiguo Lu
May 30, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Kim VaipheiRakesh Kochhar
Mar 31, 2018·Frontiers in Immunology·Maarten VerstevenEva Lion

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.